112 related articles for article (PubMed ID: 7785944)
1. A rapid method for measurement of the susceptibility to oxidation of low-density lipoprotein.
McDowell IF; McEneny J; Trimble ER
Ann Clin Biochem; 1995 Mar; 32 ( Pt 2)():167-74. PubMed ID: 7785944
[TBL] [Abstract][Full Text] [Related]
2. A simple method for assessing copper-mediated oxidation of very-low-density lipoprotein isolated by rapid ultracentrifugation.
McEneny J; Trimble ER; Young IS
Ann Clin Biochem; 1998 Jul; 35 ( Pt 4)():504-14. PubMed ID: 9681052
[TBL] [Abstract][Full Text] [Related]
3. Improved measurement of low-density-lipoprotein susceptibility to copper-induced oxidation: application of a short procedure for isolating low-density lipoprotein.
Kleinveld HA; Hak-Lemmers HL; Stalenhoef AF; Demacker PN
Clin Chem; 1992 Oct; 38(10):2066-72. PubMed ID: 1394991
[TBL] [Abstract][Full Text] [Related]
4. The in vitro and ex vivo antioxidant properties, and hypolipidemic activity of CGP 2881.
Feldman DL; Mogelesky TC; Sharif R; Sawyer WK; Jeune M; Hu CW; Leonards KS; Prescott MF
Atherosclerosis; 1999 Jun; 144(2):343-55. PubMed ID: 10407495
[TBL] [Abstract][Full Text] [Related]
5. Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification.
Ishikawa T; Suzukawa M; Ito T; Yoshida H; Ayaori M; Nishiwaki M; Yonemura A; Hara Y; Nakamura H
Am J Clin Nutr; 1997 Aug; 66(2):261-6. PubMed ID: 9250103
[TBL] [Abstract][Full Text] [Related]
6. Oxidation resistance of LDL in hypertriglyceridaemic patients treated with ciprofibrate.
Nagyová A; Raslová K; Ginter E
Physiol Res; 1998; 47(3):185-90. PubMed ID: 9803483
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of low density lipoprotein oxidation by thyronines and probucol.
Hanna AN; Feller DR; Witiak DT; Newman HA
Biochem Pharmacol; 1993 Feb; 45(3):753-62. PubMed ID: 8442772
[TBL] [Abstract][Full Text] [Related]
8. Reduced susceptibility to oxidation of low-density lipoprotein in patients with overproduction of nitric oxide (Bartter's and Gitelman's syndrome).
Calò L; Sartore G; Bassi A; Basso C; Bertocco S; Marin R; Zambon S; Cantaro S; D'Angelo A; Davis PA; Manzato E; Crepaldi G
J Hypertens; 1998 Jul; 16(7):1001-8. PubMed ID: 9794741
[TBL] [Abstract][Full Text] [Related]
9. Effects of some flavonoids on the susceptibility of low-density lipoprotein to oxidative modification.
Safari MR; Rezaie M; Sheikh N
Indian J Biochem Biophys; 2003 Oct; 40(5):358-61. PubMed ID: 22900331
[TBL] [Abstract][Full Text] [Related]
10. A rapid and simple method for measuring the susceptibility of low-density-lipoprotein and very-low-density-lipoprotein to copper-catalyzed oxidation.
Zhang A; Vertommen J; Van Gaal L; De Leeuw I
Clin Chim Acta; 1994 Jun; 227(1-2):159-73. PubMed ID: 7955412
[TBL] [Abstract][Full Text] [Related]
11. Novel 3,5-diaryl pyrazolines and pyrazole as low-density lipoprotein (LDL) oxidation inhibitor.
Jeong TS; Kim KS; Kim JR; Cho KH; Lee S; Lee WS
Bioorg Med Chem Lett; 2004 Jun; 14(11):2719-23. PubMed ID: 15125921
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin active metabolite inhibits oxidative modification of small dense low-density lipoprotein.
Jacob RF; Walter MF; Self-Medlin Y; Mason RP
J Cardiovasc Pharmacol; 2013 Aug; 62(2):160-6. PubMed ID: 23575262
[TBL] [Abstract][Full Text] [Related]
13. When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid.
Bagnati M; Perugini C; Cau C; Bordone R; Albano E; Bellomo G
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):143-52. PubMed ID: 10229669
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein oxidation and measurement of thiobarbituric acid reacting substances formation in a single microtiter plate: its use for evaluation of antioxidants.
Wallin B; Rosengren B; Shertzer HG; Camejo G
Anal Biochem; 1993 Jan; 208(1):10-5. PubMed ID: 8434778
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation?
Sasahara M; Raines EW; Chait A; Carew TE; Steinberg D; Wahl PW; Ross R
J Clin Invest; 1994 Jul; 94(1):155-64. PubMed ID: 8040256
[TBL] [Abstract][Full Text] [Related]
16. The effect of probucol on low density lipoprotein oxidation and femoral atherosclerosis.
Regnström J; Walldius G; Nilsson S; Elinder LS; Johansson J; Mölgaard J; Holme I; Olsson AG; Nilsson J
Atherosclerosis; 1996 Sep; 125(2):217-29. PubMed ID: 8842353
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein B carbonyl formation is enhanced by lipid peroxidation during copper-mediated oxidation of human low-density lipoproteins.
Yan LJ; Lodge JK; Traber MG; Packer L
Arch Biochem Biophys; 1997 Mar; 339(1):165-71. PubMed ID: 9056246
[TBL] [Abstract][Full Text] [Related]
18. Lipid peroxidation and susceptibility of low-density lipoprotein to in vitro oxidation in hyperhomocysteinaemia.
Blom HJ; Kleinveld HA; Boers GH; Demacker PN; Hak-Lemmers HL; Te Poele-Pothoff MT; Trijbels JM
Eur J Clin Invest; 1995 Mar; 25(3):149-54. PubMed ID: 7781660
[TBL] [Abstract][Full Text] [Related]
19. Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed.
Ahmad F; Leake DS
Chem Phys Lipids; 2018 Jul; 213():13-24. PubMed ID: 29518380
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of multi-substituted benzylidenethiazolidine-2,4-diones on LDL oxidation.
Jeong TS; Kim JR; Kim KS; Cho KH; Bae KH; Lee WS
Bioorg Med Chem; 2004 Aug; 12(15):4017-23. PubMed ID: 15246079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
